(NP (NP-COOD (NP (NN Identification)) (CC and) (NP (NN characterization))) (PP (IN of) (NP (NP (DT a) (JJ leukocyte-specific) (NN component)) (PP (IN of) (NP (DT the) (JJ nuclear) (NN body))))) (. .))
(S (NP-SBJ (NP (DT The) (JJ nuclear) (NN body)) (PRN (-LRB- -LRB-) (NP (NN NB)) (-RRB- -RRB-))) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ cellular) (NN organelle)) (SBAR (WHNP-74 (WDT that)) (S (NP-SBJ-75 (-NONE- *T*-74)) (VP (VBZ is) (VP (VBN involved) (NP (-NONE- *-75)) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP-COOD (NP (JJ acute) (JJ promyelocytic) (NN leukemia)) (CC and) (NP (JJ viral) (NN infection)))))))))))) (. .))
(S (NP-SBJ (DT The) (NN NB)) (VP (VBZ is) (ADVP (RB also)) (NP-PRD (NP (DT a) (NN target)) (PP (IN of) (NP (NNS antibodies))) (PP (IN in) (NP (NP (DT the) (NN serum)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (DT the) (JJ autoimmune) (NN disease) (JJ primary) (JJ biliary) (NN cirrhosis))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP-SBJ-76 (NP (NN serum)) (PP (IN from) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (JJ primary) (JJ biliary) (NN cirrhosis)))))) (VP (VBD was) (VP (VBN used) (NP (-NONE- *-76)) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB identify) (NP (NP (DT a) (NN cDNA)) (VP (VBG encoding) (NP (NP (NP (DT a) (JJ novel) (NN component)) (PP (IN of) (NP (DT the) (NN NB)))) (, ,) (NP (NP (DT a) (JJ 140-kDa) (NN protein)) (VP (VBN designated) (S (NP-SBJ (-NONE- *)) (NP-PRD (NN Sp140))))))))))))) (. .))
(S (NP-SBJ (NP (DT The) (VBN predicted) (NN amino) (NN acid) (NN sequence)) (PP (IN of) (NP (NP (DT the) (JJ amino-terminal) (NN portion)) (PP (IN of) (NP (NN Sp140)))))) (VP (VBD was) (ADJP-PRD (JJ similar) (PP (TO to) (NP (NP (NN Sp100)) (, ,) (NP (DT a) (ADJP (RB previously) (VBN identified)) (NN NB) (NN protein)))))) (. .))
(S (NP-SBJ (NP (DT The) (JJ carboxyl) (NN portion)) (PP (IN of) (NP (NN Sp140)))) (VP (VBD contained) (NP (NP-COOD (NP (DT a) (JJ zinc-finger) (NN domain)) (CC and) (NP (DT a) (NN bromodomain))) (, ,) (NP (NP (NNS motifs)) (SBAR (WHNP-77 (WDT that)) (S (NP-SBJ (-NONE- *T*-77)) (VP (VBP are) (ADJP-PRD (JJ present) (PP (IN in) (NP (NP (NNS proteins)) (VP (VBG regulating) (NP (NN gene) (NN transcription)))))))))))) (. .))
(S (NP-SBJ-78 (NP (JJ High) (NNS levels)) (PP (IN of) (NP (NN Sp140) (NN mRNA)))) (VP (VBD were) (VP (VBN detected) (NP (-NONE- *-78)) (PP (IN in) (NP-COOD (NP (JJ human) (NP-COOD (NP (NN spleen)) (CC and) (NP (JJ peripheral) (NN blood))) (NNS leukocytes)) (, ,) (CONJP (CC but) (RB not)) (NP (JJ other) (JJ human) (NNS tissues)))))) (. .))
(S (NP-SBJ (NP (DT The) (NN level)) (PP (IN of) (NP (NN SP140) (NN mRNA))) (PP (IN in) (NP (JJ myeloid) (NN precursor) (NN cell) (NNS lines) (NP-COOD (NP (NN HL60)) (CC and) (NP (NN NB4)))))) (ADVP (RB markedly)) (VP (VBD increased) (PP (IN in) (NN response) (TO to) (NP (ADJP (RB chemically) (VBN induced)) (JJ cellular) (NN differentiation)))) (. .))
(S (NP-SBJ-79 (JJ Immunohistochemical) (NNS techniques)) (VP (VBD were) (VP (VBN used) (NP-80 (-NONE- *-79)) (S (NP-SBJ (-NONE- *-80)) (VP (TO to) (VP (VB demonstrate) (SBAR (IN that) (S (NP-SBJ (NN SP140)) (VP (VBD localized) (PP (TO to) (NP (DT the) (NN NB))) (PP (IN in) (NP (VBN differentiated) (NP-COOD (NP (NN HL60)) (CC and) (NP (NN NB4))) (NNS cells))))))))))) (. .))
(S (NP-SBJ-COOD (NP (NP (DT The) (NN location)) (PP (IN of) (NP (NN Sp140))) (PP (IN in) (NP (DT the) (NN NB)))) (, ,) (CC and) (NP (NP (NN expression)) (PP (IN of) (NP (DT this) (NN gene))) (PP (IN in) (NP (NP (NNS cells)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (NN host) (NN defense))))))) (, ,)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ-81 (NN Sp140)) (VP (MD may) (VP (VB be) (VP (VBN involved) (NP (-NONE- *-81)) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP-COOD (NP (JJ acute) (JJ promyelocytic) (NN leukemia)) (CC and) (NP (JJ viral) (NN infection)))))))))))) (. .))
